Serum squamous cell carcinoma (SCC) for squamous cell tumors and cancer antigen 125 (CA125) levels for adenocarcinoma in cervical cancer are also used to evaluate disease stage, response to therapy, and relapse of tumors. The gene discussed is MUC16; the disease is squamous cell neoplasm.